Details of the Drug | DrugMAP

General Information of Drug (ID: DMQWU5P)

Drug Name

Thymocartin

Synonyms

Timocartin; RGH-0206

Indication

Disease Entry	ICD 11	Status	REF
Hodgkin lymphoma	2B30	Discontinued in Phase 3	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C21H40N8O7
Canonical SMILES: CC(C)C(C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)N
InChI: 1S/C21H40N8O7/c1-11(2)16(20(35)36)29-19(34)14(10-15(30)31)28-18(33)13(7-3-4-8-22)27-17(32)12(23)6-5-9-26-21(24)25/h11-14,16H,3-10,22-23H2,1-2H3,(H,27,32)(H,28,33)(H,29,34)(H,30,31)(H,35,36)(H4,24,25,26)/t12-,13-,14-,16-/m0/s1
InChIKey: COIXXKVZEXZCLU-YXWQFLTLSA-N

Cross-matching ID

PubChem CID: 3033954
CAS Number: 85466-18-8
TTD ID: D0P8EU

References

1	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003196)